MacroGenics, Inc. announced its participation in four prominent investor conferences scheduled for March 2026, positioning the company for increased engagement with institutional investors and market participants. The biopharmaceutical company's management team, led by President and Chief Executive Officer Eric Risser, will attend the TD Cowen, Leerink Partners, Citizens, and Barclays healthcare conferences, providing investors with direct access to company leadership.
The company plans to conduct formal presentations alongside fireside chat sessions and facilitate one-on-one meetings with investors at each event. This multi-conference roadshow represents a standard corporate communications strategy employed by biopharmaceutical firms to maintain investor relations and provide market updates on pipeline developments and business operations.
Webcast recordings of the company's presentations will be made available through MacroGenics' investor relations website, extending access to presentations beyond conference attendees. This approach allows broader market participation and provides investors with on-demand access to management commentary regarding the company's strategic priorities and financial performance outlook.